Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA652011CFO, Treasurer & Vice President-Finance
Robert Ehlinger602006Chief Information Officer & VP-logistics
Kristin A. Arnold, PhD-2017Vice President-Research & Development
David A. Drabik482010Lead Independent Director
Paul Taveira572012Independent Director
James M. Maher642013Independent Director
Albert R. Paonessa III562015Independent Director
Patrick G. LePore, MBA622017Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,837,305 27,218,173 71.9% 606,734 1.6% 71.9%
Shareholders
NameEquities%
Telemus Capital LLC 6,019,820 16.2%
Jeffrey Farber 4,650,851 12.5%
David J. Farber 3,779,904 10.2%
BlackRock Fund Advisors 3,632,800 9.76%
Snow Capital Management LP 3,152,240 8.47%
The Vanguard Group, Inc. 2,901,885 7.79%
LSV Asset Management 1,681,535 4.52%
Deerfield Management Company LP 1,523,957 4.09%
Morgan Stanley & Co. LLC 1,146,407 3.08%
SSgA Funds Management, Inc. 1,077,622 2.89%
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.583
JOHNSON & JOHNSON15.12%355 979
NOVARTIS7.69%216 915
ROCHE HOLDING LTD.3.78%216 699
PFIZER0.59%194 554
MERCK AND COMPANY4.45%167 705
SANOFI6.97%122 127
BAYER8.85%104 602
GLAXOSMITHKLINE-4.61%94 281
BRISTOL-MYERS SQUIBB COMPANY-3.46%92 525
NOVO NORDISK A/S12.45%88 994
ELI LILLY AND COMPANY4.79%84 853
ABBOTT LABORATORIES26.89%84 683
ALLERGAN PLC6.66%74 881
ASTRAZENECA0.21%72 406
SHIRE-19.63%43 974
TAKEDA PHARMACEUTICAL CO LTD21.88%42 619
ASTELLAS PHARMA INC-14.76%26 156
JIANGSU HENGRUI MEDICINE CO., LTD18.04%22 683
CHUGAI PHARMACEUTICAL CO LTD28.46%22 007
SHIONOGI & CO LTD0.30%17 154
Connections : Lannett Company, Inc.
Kremers Urban Pharmaceuticals, Inc.
Lautus Pharmaceuticals LLC
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
The American Institute of Certified Public Accountants
AgeneBio, Inc.
Cranbrook & Co. Llc
Endo Generics Holdings, Inc.
National Response Corp.
Tyme, Inc.
Generic Pharmaceutical Co.
Villanova University
Company contact information
Lannett Co., Inc.
9000 State Road
Philadelphia, PA 19136

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2017 People , Fundamentals and Ownership